DLX1

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0030154 cell differentiation	IBA GO_REF:0000033	MODIFY	Summary: DLX1 is a central regulator of GABAergic interneuron differentiation in the forebrain and plays roles in hematopoietic cell differentiation. This IBA annotation is correct but too general for the core function. Reason: The IBA annotation is phylogenetically sound and the general statement is correct, but this term lacks the specificity needed to capture DLX1's primary role. DLX1's core developmental function is GABAergic interneuron specification and differentiation in the ventral telencephalon, where it acts downstream of ASCL1. More specific terms like GO:0097154 (GABAergic neuron differentiation) or GO:0021892 (cerebral cortex GABAergic interneuron differentiation) better represent the core function. Proposed replacements: GABAergic neuron differentiation cerebral cortex GABAergic interneuron differentiation Supporting Evidence: file:human/DLX1/DLX1-deep-research-falcon.md model: Edison Scientific Literature
GO:0005634 nucleus	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 is a nuclear transcription factor. This is a core cellular component annotation fully supported by experimental evidence. Reason: As a homeobox transcription factor, DLX1 functions in the nucleus where it binds DNA and regulates gene transcription. This is supported by IDA evidence from PMID:14671321, IBA phylogenetic inference, and functional requirement for nuclear localization. The homeodomain is necessary for nuclear localization. This is a core localization annotation. Supporting Evidence: PMID:14671321 We report here that, in addition to the previously reported regions/cells, DLX1 is expressed in hematopoietic cells in a lineage-dependent manner and that DLX1 interacts with Smad4 through its homeodomain
GO:0006357 regulation of transcription by RNA polymerase II	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 functions as a transcriptional activator or repressor through RNA polymerase II. This is a correct core function annotation. Reason: DLX1 is a sequence-specific DNA-binding transcription factor that regulates RNA pol II transcription at target genes. UniProt states it acts as transcriptional activator or repressor. This IBA annotation correctly captures this core molecular process. Supporting Evidence: PMID:14671321 the resulting complex translocates to the nucleus to regulate transcription
GO:0048706 embryonic skeletal system development	IBA GO_REF:0000033	KEEP AS NON CORE	Summary: DLX1 plays roles in craniofacial development including jaw morphogenesis and odontogenesis. This annotation represents a secondary (non-core) developmental role. Reason: DLX genes including DLX1 are expressed in pharyngeal arches and contribute to craniofacial skeletal patterning. However, this is a pleiotropic effect rather than the primary function. The core function of DLX1 is GABAergic interneuron specification in the forebrain. Craniofacial roles are developmentally important but represent secondary functions of this transcription factor.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 is a sequence-specific DNA-binding transcription factor that regulates RNA polymerase II transcription. This is a core molecular function annotation. Reason: This annotation accurately captures DLX1's primary molecular function as a homeodomain-containing transcription factor that binds specific DNA sequences to regulate transcription. Supported by multiple evidence codes (IBA, ISA, IEA) and structural domain information.
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding	IBA GO_REF:0000033	ACCEPT	Summary: DLX1 binds to specific DNA sequences (TAAT/ATTA motifs) at cis-regulatory regions including enhancers and promoters. This is a core molecular function. Reason: DLX1 contains a homeodomain that recognizes TAATTA-type DNA motifs at enhancers and promoters. Recent work shows DLX1 binds enhancers with specific motif grammar to modulate chromatin loops. This IBA annotation accurately represents the sequence-specific DNA binding activity.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IEA GO_REF:0000120	ACCEPT	Summary: Duplicate of IBA annotation above. This IEA annotation is redundant but correct. Reason: This is a duplicate annotation with different evidence (IEA vs IBA for the same term). Both are correct. IEA annotations from automated pipelines are acceptable when they correctly identify core functions, as in this case.
GO:0003677 DNA binding	IEA GO_REF:0000120	ACCEPT	Summary: DLX1 contains a homeodomain and binds DNA. However, this term is too general compared to more specific sequence-specific binding terms. Reason: While this term is very general, it is not incorrect. DLX1 does bind DNA through its homeodomain. The more specific terms (GO:0000978, GO:1990837) provide better functional detail, but this broad parent term can be retained as it is accurate. IEA annotations at this level are acceptable for coverage.
GO:0005634 nucleus	IEA GO_REF:0000120	ACCEPT	Summary: Duplicate nucleus localization annotation. Redundant with IBA and IDA annotations but correct. Reason: This is a duplicate of the IBA annotation for nucleus localization. While redundant, it is correct and represents automated inference that agrees with phylogenetic and experimental data.
GO:0006355 regulation of DNA-templated transcription	IEA GO_REF:0000002	ACCEPT	Summary: DLX1 regulates transcription. This term is correct but overlaps substantially with the more specific GO:0006357 (regulation of transcription by RNA polymerase II). Reason: This is a valid but more general annotation than GO:0006357. Both terms are in the transcription regulation hierarchy. The more specific RNA pol II term is preferable, but this general term is not incorrect and can be retained.
GO:0030154 cell differentiation	IEA GO_REF:0000043	MODIFY	Summary: Duplicate of IBA annotation above, from keyword mapping. Same assessment applies. Reason: This is a duplicate IEA annotation of the IBA annotation reviewed above. Same reasoning applies - the term is correct but too general. Should be replaced with more specific GABAergic neuron differentiation terms. Proposed replacements: GABAergic neuron differentiation
GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 binds specific sequences at transcriptional regulatory regions. This overlaps with GO:0000978 but is essentially equivalent and correct. Reason: This term is essentially synonymous with GO:0000978 (RNA polymerase II cis-regulatory region sequence-specific DNA binding) already annotated. Both accurately describe DLX1's DNA binding to regulatory elements. The slight terminology difference does not warrant modification.
GO:0003682 chromatin binding	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 engages chromatin as a transcription factor and can modulate chromatin architecture. This is a valid annotation for a DNA-binding TF. Reason: Transcription factors that bind DNA inherently interact with chromatin. Recent evidence shows DLX1 can modulate promoter-enhancer chromatin loops. While not as specific as sequence-specific DNA binding terms, chromatin binding is a valid molecular function for DLX1.
GO:0006357 regulation of transcription by RNA polymerase II	IEA GO_REF:0000107	ACCEPT	Summary: Duplicate of IBA annotation above. This IEA annotation is redundant but correct. Reason: This is another duplicate annotation of the IBA-supported GO:0006357 term. The annotation is correct and represents the core biological process regulated by DLX1.
GO:0045597 positive regulation of cell differentiation	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 promotes GABAergic interneuron differentiation and acts in hematopoietic cell differentiation. The positive regulation aspect is correct for the core GABAergic function. Reason: DLX1 positively regulates GABAergic interneuron differentiation as part of the ASCL1→DLX1/2 cascade that specifies GABAergic fate. While the term is somewhat general, the directionality (positive) is appropriate for the core function. This annotation can be retained.
GO:0045944 positive regulation of transcription by RNA polymerase II	IEA GO_REF:0000107	ACCEPT	Summary: DLX1 can act as transcriptional activator or repressor. This term captures only the activation function and may be incomplete. Reason: UniProt indicates DLX1 acts as both activator and repressor. This annotation captures the activation function. Experimental evidence from PMID:14671321 (IMP) supports positive regulation of transcription. The negative regulation is captured by GO:0000122 annotation. Both directions are biologically relevant.
GO:0046533 negative regulation of photoreceptor cell differentiation	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: DLX1 plays roles in retinal cell differentiation in developing retina, promoting amacrine and bipolar cells. This term from mouse orthologs is a peripheral function. Reason: UniProt notes DLX1 plays a role in terminal differentiation of interneurons including amacrine and bipolar cells in developing retina (by similarity from mouse). This is a valid developmental role but peripheral to the core forebrain GABAergic interneuron function. Mark as non-core.
GO:1902871 positive regulation of amacrine cell differentiation	IEA GO_REF:0000107	KEEP AS NON CORE	Summary: DLX1 promotes amacrine cell differentiation in the developing retina. This is a peripheral developmental function based on mouse data. Reason: This annotation is based on mouse ortholog data (ISS annotation exists). Amacrine cells are retinal interneurons, and this represents a developmental role of DLX genes outside the core forebrain GABAergic specification function. Valid but non-core.
GO:0005654 nucleoplasm	IDA GO_REF:0000052	ACCEPT	Summary: Nucleoplasm is a sub-compartment of the nucleus. This IDA annotation provides more specific localization information. Reason: This Human Protein Atlas IDA annotation provides more specific nuclear sub-localization data. Nucleoplasm is a valid and more specific cellular component term for a nuclear transcription factor. This complements the broader nucleus annotations.
GO:1990837 sequence-specific double-stranded DNA binding	IDA PMID:28473536 Impact of cytosine methylation on DNA binding specificities ...	ACCEPT	Summary: DLX1 binds double-stranded DNA with sequence specificity through its homeodomain. This IDA annotation provides direct experimental evidence for DNA binding. Reason: PMID:28473536 used methylation-sensitive SELEX to systematically analyze TF binding specificities. This provides direct experimental evidence for sequence-specific dsDNA binding by DLX1. This is a core molecular function appropriately supported by experimental data. Supporting Evidence: PMID:28473536 By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences. Most of these are in the extended homeodomain family
GO:0000785 chromatin	ISA GO_REF:0000113	ACCEPT	Summary: This is a cellular component annotation placing DLX1 at chromatin. Transcription factors localize to chromatin when binding DNA. Reason: This ISA annotation from TFClass database correctly places DNA-binding transcription factors at chromatin. DLX1 functions at chromatin to regulate gene transcription. This is appropriate for sequence-specific TFs.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	ISA GO_REF:0000113	ACCEPT	Summary: Another instance of the core molecular function annotation from TFClass. Redundant but correct. Reason: Third instance of this annotation with ISA evidence from TFClass database. Correct annotation for a homeodomain transcription factor.
GO:0000122 negative regulation of transcription by RNA polymerase II	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: DLX1 can act as transcriptional repressor. PMID:14671321 shows DLX1 blocks activin A signaling by interfering with SMAD-mediated transcription. Reason: PMID:14671321 demonstrated that DLX1 interacts with SMAD4 and blocks TGF-beta superfamily signaling, effectively acting as a transcriptional repressor in this context. The IMP evidence shows DLX1 can negatively regulate transcription. This complements the positive regulation annotation and reflects the dual activator/repressor role noted in UniProt. Supporting Evidence: PMID:14671321 We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4, including differentiation of a hematopoietic cell line by activin A
GO:0005515 protein binding	IPI PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	REMOVE	Summary: Generic protein binding annotation based on SMAD4 interaction. This term is not informative about specific function. Reason: While technically correct (DLX1 does bind SMAD4), the generic "protein binding" term provides no functional information and should be avoided per curation guidelines. If a more specific term for SMAD binding or transcription factor binding exists, that would be preferable, but the generic protein binding term should be removed. Supporting Evidence: PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.
GO:0005634 nucleus	IDA PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: Another nucleus annotation with direct IDA evidence. Redundant with other nucleus annotations but experimentally supported. Reason: This IDA annotation from PMID:14671321 provides direct experimental evidence for nuclear localization. While redundant with IBA and other evidence, experimental confirmation of localization is valuable. Supporting Evidence: PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.
GO:0030514 negative regulation of BMP signaling pathway	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 inhibits BMP4 signaling by interfering with SMAD-mediated transcription. This is experimentally demonstrated but represents a secondary regulatory role in hematopoietic cells. Reason: PMID:14671321 demonstrated that DLX1 blocks BMP4 signaling in hematopoietic cells through interaction with SMAD4. This is a valid regulatory function but is not the core developmental role of DLX1. The primary function is GABAergic interneuron specification in the forebrain. This BMP regulation represents a secondary function in hematopoietic contexts. Supporting Evidence: PMID:14671321 We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4
GO:0045944 positive regulation of transcription by RNA polymerase II	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	ACCEPT	Summary: DLX1 can act as transcriptional activator. This IMP annotation provides experimental evidence for the activation function. Reason: This IMP annotation from PMID:14671321 provides experimental evidence for DLX1's role as transcriptional activator. Together with the GO:0000122 negative regulation annotation, this captures the dual activator/repressor function. Core annotation. Supporting Evidence: PMID:14671321 DLX1 has been reported to be temporally and spatially coexpressed with BMP-4 during embryogenesis in selected contexts
GO:0071560 cellular response to transforming growth factor beta stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 responds to and modulates TGF-beta signaling in hematopoietic cells. This is a secondary regulatory function in specific cellular contexts. Reason: PMID:14671321 shows DLX1 participates in cellular responses to TGF-beta superfamily ligands by blocking SMAD signaling. This is a valid function but specific to hematopoietic cell contexts. Not a core developmental function related to GABAergic interneuron specification. Supporting Evidence: PMID:14671321 these cytokines bind to their respective receptor, a regulatory Smad is phosphorylated and becomes associated with Smad4, the common Smad, and the resulting complex translocates to the nucleus to regulate transcription
GO:0071773 cellular response to BMP stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 modulates cellular responses to BMP signaling in hematopoietic cells. Secondary regulatory function in specific contexts. Reason: Similar to TGF-beta response, this annotation captures DLX1's role in modulating BMP signaling in hematopoietic cells. Valid but peripheral to core forebrain GABAergic function. Supporting Evidence: PMID:14671321 DLX1 interacts with Smad4 through its homeodomain. We show that it blocks multiple signals from TGF-beta superfamily cytokines such as activin A, TGF-beta1, and BMP-4
GO:1903845 negative regulation of cellular response to transforming growth factor beta stimulus	IMP PMID:14671321 Homeoprotein DLX-1 interacts with Smad4 and blocks a signali...	KEEP AS NON CORE	Summary: DLX1 negatively regulates cellular responses to TGF-beta by blocking SMAD signaling. Secondary function in hematopoietic contexts. Reason: This annotation captures the mechanistic role of DLX1 in blocking TGF-beta signaling responses through SMAD4 interaction. Experimentally supported but represents a regulatory function in hematopoietic cells rather than the core developmental role. Supporting Evidence: PMID:14671321 Taken together, these data suggest that DLX1 may function as a regulator of multiple signals from TGF-beta superfamily members in broad biological contexts during blood production
GO:0045597 positive regulation of cell differentiation	ISS GO_REF:0000024	ACCEPT	Summary: Duplicate ISS annotation of the IEA annotation above. Same assessment - correct but general. Reason: This ISS annotation based on mouse ortholog agrees with other evidence that DLX1 positively regulates differentiation, particularly GABAergic interneuron differentiation. The annotation is correct though general.
GO:0045944 positive regulation of transcription by RNA polymerase II	ISS GO_REF:0000024	ACCEPT	Summary: Duplicate ISS annotation based on mouse ortholog. Same assessment as IMP and IEA versions - correct core function. Reason: This ISS annotation based on mouse Dlx1 ortholog correctly identifies the transcriptional activation function. Agrees with IMP experimental evidence.
GO:0046533 negative regulation of photoreceptor cell differentiation	ISS GO_REF:0000024	KEEP AS NON CORE	Summary: Duplicate ISS annotation for retinal development function. Same assessment as IEA version - valid but non-core. Reason: This ISS annotation based on mouse ortholog data represents the same retinal development function as the IEA annotation above. Valid developmental role but peripheral to core forebrain GABAergic interneuron function.
GO:1902871 positive regulation of amacrine cell differentiation	ISS GO_REF:0000024	KEEP AS NON CORE	Summary: Duplicate ISS annotation for amacrine cell differentiation. Same assessment as IEA version - valid but non-core. Reason: This ISS annotation based on mouse ortholog represents the same retinal amacrine cell function as the IEA annotation. Valid but non-core developmental role.

Gene Description

Proposed New Ontology Terms

GABAergic interneuron fate commitment

ventral forebrain GABAergic interneuron migration

Existing Annotations Review

Core Functions

Core transcription factor function - DLX1 binds TAATTA-type DNA motifs at enhancers and promoters to regulate RNA polymerase II transcription, acting as both activator and repressor. Essential for GABAergic interneuron specification in the ventral telencephalon.

Sequence-specific DNA binding function - DLX1 recognizes and binds specific TAAT/ATTA DNA sequences at cis-regulatory regions through its homeodomain. Can modulate chromatin architecture and promoter-enhancer loop topology in a motif-dependent manner.

References

Deep Research

Falcon

📄 View Raw YAML